- Wilmington, Delaware, United States
- On-site
- Full-time · Senior
- 6–10 years
Develop and apply innovative approaches to identify, characterize, and mitigate safety risks associated with small molecules and emerging modalities.
Responsibilities
- Develop and execute investigative toxicology strategies to elucidate mechanisms of toxicity and address potential safety liabilities.
- Design and apply fit-for-purpose in vitro and ex vivo models and new approach methodologies (NAMs), including advanced 2D and 3D cultures, organoids, co-cultures, and organ-on-a-chip systems.
- Evaluate and implement emerging technologies, automation, and high-throughput approaches to improve toxicity prediction and translational safety assessment.
- Design and oversee in vivo investigative studies and integrate mechanistic, computational, and multi-omics data to identify safety liabilities, biomarkers, and translational relationships.
- Collaborate with nonclinical safety scientists and cross-functional teams to translate scientific findings into actionable safety strategies and portfolio decisions.
Requirements
- Ph.D. in Toxicology, Pharmacology, Cell Biology, or a related discipline